The opportunity ahead is significant. Humanized AI can close the gaps that lead to disengagement, improve outcomes through proactive communication, and give providers the bandwidth to focus where they’re needed most. The post Humanized AI: No Longer Optional for Digital Patient Engagement appeared first on MedCity News.
The Trump administration’s healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 17: Is…
For a while, walking the dog felt hazardous. Earl Vickers was accustomed to taking Molly, his shepherd-boxer-something-else mix, for strolls on the beach or around his neighborhood in Seaside, California. A few years ago, though, he started to experience problems staying upright. “If another dog came toward us, every single time I’d end up on…
From cardiovascular disease to Alzheimer’s, the retina is proving to be the body’s most revealing health monitor, positioning optometrists at the forefront of early detection and integrated care. The post Eyes on the Future: How Retinal Imaging Is Reframing Preventive Medicine appeared first on MedCity News.
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
Little Otter’s $9.5 million fundraise included participation from Pivotal Ventures, Torch Capital, Springbank, CRV, Next Legacy, G9, Gratitude Railroad and Carrie Walton Penner’s Fiore Ventures. The company has raised more than $36 million to date. The post Little Otter Raises $9.5M for Family Mental Health appeared first on MedCity News.
[Sponsored] Executives from health tech companies attending HLTH 2025 shared how they’re integrating AI and what they’re doing to address rising healthcare costs. The post Heard at HTH: Healthcare Executives Share New Products, Strategies, Outlook appeared first on MedCity News.
A Texas boy’s second dose of the MMRV vaccine cost over $1,400. A Pennsylvania woman’s long-acting birth control cost more than $14,000. Treatment for a Florida Medicaid enrollee’s heart attack cost nearly $78,000 — about as much as surgery for an uninsured Montana woman’s broken arm. In 2025, these patients were among the hundreds who…
Leucovorin is now approved for cerebral folate deficiency months after FDA Commissioner Marty Makary claimed the decades-old generic drug had promise for treating autism. The FDA’s review was based on published literature and real-world evidence. The post FDA Drug Approval Marks a First for a Disease — But It’s Not Autism appeared first on MedCity…
The American Cancer Society struck a multi-year collaboration with Layer Health, a healthcare AI company that uses LLMs to improve data abstraction and generate insights. The partners will abstract data from thousands of medical charts of patients enrolled in the American Cancer Society’s research studies, with the ultimate goal of shortening research timelines. The post…